Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1
4(100.0%)
4Total
Phase 1(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07476963Phase 1Not Yet Recruiting

Evaluation of the Food Effecton the Pharmacokinetics of FWD1802 in Healthy Subjects

Role: lead

NCT06064812Phase 1Recruiting

A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.

Role: lead

NCT07002177Phase 1Recruiting

A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC

Role: lead

NCT05068024Phase 1Unknown

A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer

Role: lead

All 4 trials loaded